Our hypothesis led to the identification of DUSP6 as a potential synthetic lethal target in melanoma with BRAF V600E mutation and high expression of DUSP6, suggesting that, in certain scenarios, this tumor suppressor may serve as drug target. The gene discussed is DUSP6; the disease is melanoma.